Investor News 2002

December 20, 2002
Bayer reaches agreement with U.S. authorities
Download ( PDF, 59 KB ) collect
December 16, 2002
FDA Approves Once-Daily Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs)
Download ( PDF, 122 KB ) collect
December 6, 2002
Plans for the future of Pharmaceuticals have the support of the Supervisory Board
Download ( PDF, 94 KB ) collect
December 5, 2002
Strategic options for Rhein Chemie under review
Download ( PDF, 26 KB ) collect
December 5, 2002
New rules for Corporate Governance
Download ( PDF, 27 KB ) collect
December 2, 2002
Bayer and GlaxoSmithKline: Two New Studies on Erectile Dysfunction Presented
Download ( PDF, 30 KB ) collect
November 29, 2002
Acarbose - Findings of the first large-scale study
Download ( PDF, 65 KB ) collect
November 22, 2002
Vardenafil Receives Positive Opinion from European Committee for Proprietary Medicinal Products
Download ( PDF, 68 KB ) collect
November 13, 2002
Bayer CropScience to sell additional products to Makhteshim-Agan
Download ( PDF, 67 KB ) collect
November 12, 2002
Q3 2002 Statement
Download ( PDF, 685 KB ) collect
November 11, 2002
Bayer sells household insecticides for EUR 725 million to SC Johnson
Download ( PDF, 64 KB ) collect
October 30, 2002
Bayer Submits Additional New Drug Application For Once-Daily Cipro XR in U.S.
Download ( PDF, 62 KB ) collect
October 28, 2002
Rolf Classon Appointed Chairman of the Board of Management of Bayer HealthCare AG
Download ( PDF, 58 KB ) collect
October 28, 2002
Bayer CropScience AG to sell a range of products to BASF
Download ( PDF, 66 KB ) collect
October 28, 2002
Bayer's Cipro Patent Affirmed by U.S. Courts
Download ( PDF, 63 KB ) collect
October 16, 2002
Bayer and SC Johnson have signed Letter of Intent
Download ( PDF, 59 KB ) collect
October 4, 2002
Bayer plans to sell Rhein Chemie to Advent International
Download ( PDF, 67 KB ) collect
October 2, 2002
Bayer CropScience agrees to products divestments to Makhteshim-Agan
Download ( PDF, 62 KB ) collect
October 1, 2002
Approval of 200 liter fermenters for Kogenate increases production capacity for the U.S.
Download ( PDF, 67 KB ) collect
October 1, 2002
Bayer CropScience becomes first legally independent subgroup
Download ( PDF, 58 KB ) collect

October 1, 2002
Study Comparing Once-Daily Cipro XR to Conventional Twice-Daily Cipro

Download ( PDF, 86 KB ) collect
September 23, 2002
ISSIR Congress: New Vardenafil Data
Download ( PDF, 90 KB ) collect
September 18, 2002
Bayer CropScience agrees to sell wheat herbicide to Arvesta Corporation
Download ( PDF, 65 KB ) collect
September 12, 2002
Bayer cuts a further 4,700 jobs worldwide
Download ( PDF, 66 KB ) collect
August 27, 2002
New Immune Globulin Intravenous Treatment for Approval in Key Global Markets Submitted
Download ( PDF, 63 KB ) collect
August 15, 2002
Pharmaceuticals Division signs declaration of intent to market telmisartan
Download ( PDF, 66 KB ) collect
August 01, 2002
Stockholder's Newsletter 2002: Interim Report for the First Half
Download ( PDF, 582 KB ) collect
July 24, 2002
Bayer agrees to acquire Visible Genetics Inc. for US$ 61.4 million
Download ( PDF, 72 KB ) collect
July 24, 2002
FDA approvable letter for Vardenafil
Download ( PDF, 72 KB ) collect
July 17, 2002
Bayer plans to sell Haarmann & Reimer to EQT
Download ( PDF, 83 KB ) collect
June 03, 2002
Bayer CropScience ready for launch
Download ( PDF, 72 KB ) collect
May 31, 2002
Bayer to keep fibers business
Download ( PDF, 58 KB ) collect
May 31, 2002
FTC gives the green light for Bayer to acquire Aventis CropScience
Download ( PDF, 66 KB ) collect
May 30, 2002
Bayer sells stake in Agfa-Gevaert
Download ( PDF, 11 KB ) collect
May 22, 2002
Bayer taking additional steps to realign cost base of Pharmaceutical Business
Download ( PDF, 84 KB ) collect

May 21, 2002
New BAY 43-9006 Phase I data presented at 2002 ASCO meeting

Download ( PDF, 111 KB ) collect
May 13, 2002
New EUR 170 million TDA plant
Download ( PDF, 12 KB ) collect
May 02, 2002
Avalox i.v. approved in Germany: noticeable drop in treatment costs possible
Download ( PDF, 77 KB ) collect
April 26, 2002
Information for Stockholders 2002: Interim Report for the First Quarter
Download ( PDF, 171 KB ) collect

April 25, 2002
Moxifloxacin IV Reduces Healthcare Costs and Provides Excellent Outcome for Patients hospitalized with Community-Acquired Pneumonia

Download ( PDF, 74 KB ) collect
April 17, 2002
Bayer divests generics business in Spain
Download ( PDF, 69 KB ) collect
April 17, 2002
European Commission clears planned transaction:Bayer can acquire Aventis CropScience
Download ( PDF, 12 KB ) collect
April 15, 2002
New Bayer management team now complete
Download ( PDF, 90 KB ) collect
April 04, 2002
Bayer Pharma France sells generics business to Teva
Download ( PDF, 9 KB ) collect
March 25, 2002
Bayer's euro bonds a resounding success
Download ( PDF, 83 KB ) collect
March 13, 2002
Bayer expects much higher net income in 2002
Download ( PDF, 239 KB ) collect
March 12, 2002
Bayer plans to divest household insecticides
Download ( PDF, 83 KB ) collect

March 08, 2002
Bayer Corporation Submits New Drug Application for Once-Daily Formulation of Ciprofloxacin HCI and Ciprofloxacin

Download ( PDF, 132 KB ) collect
March 07, 2002
Klaus Kühn and Dr. Richard Pott appointed to the Bayer Management Board
Download ( PDF, 16 KB ) collect
March 07, 2002
Bayer to pay dividend of EUR 0.90 per share
Download ( PDF, 10 KB ) collect
March 06, 2002
Active ingredient in Aspirin reduces the risk of myocardial infarction and stroke
Download ( PDF, 13 KB ) collect
February 26, 2002
Patients Reported Vardenafil Significantly Improved Erectile Function Following Radical Prostatectomy
Download ( PDF, 76 KB ) collect
February 20, 2002
Bayer and Aventis Sign Letter of Intent on Joint Venture of Blood Plasma Business
Download ( PDF, 13 KB ) collect
February 05, 2002
Bayer receives offer for generics business in France
Download ( PDF, 50 KB ) collect
January 31, 2002
Bayer and GlaxoSmithKline Announce: EMEA Acceptance of Regulatory Filing for Vardenafil
Download ( PDF, 57 KB ) collect
January 24, 2002
Bayer stock makes its debut on the New York Stock Exchange
Download ( PDF, 12 KB ) collect
January 22, 2002
"New" Bayer Group will be more flexible to boost competitiveness and performance
Download ( PDF, 20 KB ) collect
January 11, 2002
Syngenta and Bayer reach agreement on patent disputes
Download ( PDF, 10 KB ) collect
January 09, 2002
Dr. Wolfgang Plischke appointed new General Manager of the Pharmaceuticals Business Group
Download ( PDF, 9 KB ) collect
January 09, 2002
Bayer and Burrill & Company form diagnostics capital fund
Download ( PDF, 61 KB ) collect
Last updated: December 06, 2013 Copyright © Bayer AG